Studi Preeliminari Suplementasi Produk Herbal Antidiabetes Terhadap Kontrol Glikemik Pasien Diabetes Mellitus Tipe II
DOI:
10.29303/jpm.v16i1.1662Published:
2021-01-12Issue:
Vol. 16 No. 1 (2021): Januari 2021Keywords:
Preeliminary study, antidiabetic herbal supplement, T2DMArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
The aim of this preliminary study is to compare the effect of supplement herbal product (contained the combination of extract Phaesolus vulgaris àand Momordica charantia) and control for short term glycemic control in patient with diabetes mellitus type 2. A randomised clinical trial using paralel design subject has been done in patient with diabetes mellitus type II that meet inclusion criteria (n=60, each group consist of 30 patients). The research held on two public health center in Mataram. The participant alocated on two groups which are the group that got oral hypoglicemic medicine with the herbal product and the control group that only got oral hypoglicemic medicine. The character demographic of the patient and the result of the therapy was obtained by patient interviewed and physical assesment. Fasting Blood Glucose was measured on day 0, 7 and 14. The character demographic was analyzed using chi squared test, and there were no signifficant different on both treated and controlled group (p>0,05). There were also no signifficant different found between control and the treated group (0.73 ñ 93,06 ;23,83 ñ 100,94) on day 7 and day 14 analyzed using t-test. According to this study, the combination between supplement herbal product and oral hypoglicemic medicine does not improved glycemic control on patient with diabetes mellitus type 2. Bias in this studies encourages improvement in design and management of further studies.
ÃÂ
References
Indonesia, P. E. (2015). Pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Pb. Perkeni.
Chang, C. L., Lin, Y., Bartolome, A. P., Chen, Y. C., Chiu, S. C., & Yang, W. C. (2013). Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evidence-Based Complementary and Alternative Medicine, 2013.
Dalimartha, S. (2000). Atlas tumbuhan obat Indonesia (Vol. 2). Niaga Swadaya.
Ekasari, W. (2018). Tanaman dan Kesehatan : Terapi Alternatif Tiga Penyakit Utama Dengan Bukti Ilmiah. Indomedia Pustaka: Sidoarjo hal. 15-17
Lim, T. K. (2015). Colocasia esculenta. In Edible medicinal and non medicinal plants (pp. 454-492). Springer, Dordrecht.
Nugrahani, R., Andayani, Y., & Hakim, A. (2017). Skrining fitokimia dari ekstrak buah buncis (Phaseolus vulgaris L) dalam sediaan serbuk. Procedia Kimia, 1(1).
Steiner, D., Marçon, C. R., & Sabban, E. N. C. (2018). Diabetes, non-enzymatic glycation, and aging. In Dermatology and Diabetes (pp. 243-279). Springer, Cham.
Singhal, P., Kaushik, G., & Mathur, P. (2014). Antidiabetic potential of commonly consumed legumes: a review. Critical reviews in food science and nutrition, 54(5), 655-672.
Nyau, V. (2014). Nutraceutical perspectives and utilization of common beans (Phaseolus vulgaris L.): A Review. African Journal of Food, Agriculture, Nutrition and Development, 14(7), 9483-9496.
Andayani, Y. (2003). Mekanisme aktivitas antihiperglikemik ekstrak buncis (Phaseolus vulgaris linn) pada tikus diabetes dan identifikasi Komponen aktif. Disertasi. Bogor: Institut Pertanian Bogor.
Bortolotti, M., Mercatelli, D., & Polito, L. (2019). Momordica charantia, a nutraceutical approach for inflammatory related diseases. Frontiers in pharmacology, 10, 486.
Joseph, B., & Jini, D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacific Journal of Tropical Disease, 3(2), 93-102.
Peter, E. L., Kasali, F. M., Deyno, S., Mtewa, A., Nagendrappa, P. B., Tolo, C. U., ... & Sesaazi, D. (2019). Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. Journal of ethnopharmacology, 231, 311-324.
Achmad, A. (2016). Efektivitas Ekstrak Buah Pare (Momordica charantia) dan Buncis (Phaseolus vulgaris) untuk Penurunan Kadar Gula Darah dan AUC (Area Under Curve). Pharmaceutical Journal of Indonesia, 2(1), 25-29.
Azam, M., Saerang, C., Rahayu, S. R., Indrawati, F., Budiono, I., Fibriana, A. I., ... & Lesmana, R. (2016). A Doubled-Blind, Crossover-RCT in T2DM for Evaluating Hypoglycemic effect of P. indicus, M. charantia, P. vulgaris and A. Paniculata in Central Java. J. Nat. Remedies, 16, 108-114.
Hayati, R., Sari, A., & Alfina, N. (2019). Serbuk effervescent kombinasi ekstrak buah pare (Momordica charantia L.) dan buncis (Phaseolus vulgaris L.) sebagai nutraseutikal. AcTion: Aceh Nutrition Journal, 4(1), 42-48.
Maripa, B. R., Andayani, Y., & Savalas, L. R. T. (2019). Uji Kualitas Obat Tradisional Antidiabetes Dari Buah Buncis Dan Buah Pare. JPPIPA (Jurnal Penelitian Pendidikan IPA), 5(1).
Valluri, A. (2015). Reverse Pharmacology. ââ¬ÅA new outlook in the drug development processââ¬Â, International Journal of Allied Medical Sciences and Clinical Research 3(4).
Rahmatini, R. (2015). Evaluasi Khasiat Dan Keamanan Obat (Uji Klinik). Majalah Kedokteran Andalas, 34(1), 31-38.
Afrianti, R., Yenti, R., & Meustika, D. (2014). Uji aktifitas analgetik ekstrak etanol daun pepaya (Carica papaya L.) pada mencit putih jantan yang di induksi asam asetat 1%. Jurnal Sains Farmasi & Klinis, 1(1), 54-60.
Kemenkes, R. I. (2011). Pedoman Teknis Penemuan dan Tatalaksana Penyakit Diabetes Melitus.
Burton, C. A. C., Holmes, J., Murray, J., Gillespie, D., Lightbody, C. E., Watkins, C. L., & Knapp, P. (2011). Interventions for treating anxiety after stroke. Cochrane Database of Systematic Reviews, (12).
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., ... & Weiss, R. (2015). Type 2 diabetes mellitus. Nature reviews Disease primers, 1(1), 1-22.
Author Biographies
Yayuk Andayani, Program Studi Pendidikan Kimia FKIP Universitas Mataram
Siti Rahmatul Aini, Program Studi Farmasi Fakultas Kedokteran Universitas Mataram
Iman Surya Pratama, Program Studi Farmasi Fakultas Kedokteran Universitas Mataram
Ni Made Ratnata Amalia, Program Studi Farmasi Fakultas Kedokteran Universitas Mataram
Lalu Husnul Hidayat, Program Studi Farmasi Fakultas Kedokteran Universitas Mataram
License
The following terms apply to authors who publish in this journal:
1. Authors retain copyright and grant the journal first publication rights, with the work simultaneously licensed under a Creative Commons Attribution License 4.0 International License (CC-BY License) that allows others to share the work with an acknowledgment of the work's authorship and first publication in this journal.
2. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., posting it to an institutional repository or publishing it in a book), acknowledging its initial publication in this journal.
3. Before and during the submission process, authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website), as this can lead to productive exchanges as well as earlier and greater citation of published work (See The Effect of Open Access).
